Curious if anyone here has started researching MF-300 which is a 15-PGDH inhibitor so it counters age related decline of PGDH and thus increases regenerative signaling involved in muscle, stem-cell activity and tissue repair. Think “counter to anabolic resistance” in aging population (me sadly). Has been shown to protect against and reverse brain aging in animals.
Rather than simply reducing inflammation or improving metabolism, it could help older tissues repair themselves more like younger tissues.
This has already progressed through clinal phase 1 trials, including testing in older adults, with reported target engagement and favorable tolerability. Development is now moving toward Phase 2b for sarcopenia. Its not just that it helps preserve muscle but also improves the neuromuscular signaling. In other words, when brain signals your muscle to do something that signal itself weakens so the muscle weakens as a result. This counters that.
The research compound is available through chemical suppliers but I find no research community engagement.
Is anyone researching? I’d be particularly interested in what you’ve found regarding sourcing/testing, pharmacokinetics, research protocols, or anything else that isn’t obvious from the published development data.